News

Filter

Current filters:

HerceptinRoche

1 to 9 of 267 results

Roche shares fall sharply on disappointing Ph III MARIANNE study

Roche shares fall sharply on disappointing Ph III MARIANNE study

22-12-2014

Swiss pharma major Roche saw its shares plunge 6.4% to 270.40 Swiss francs on Friday following release…

BiotechnologyGenentechHerceptinKadcylaOncologyPerjetaRoche

Roche could lose its dominant market share in breast cancer, says IMS report

Roche could lose its dominant market share in breast cancer, says IMS report

03-10-2014

Biosimilars and new generation agents will end the market dominance of established breast cancer drugs,…

AstraZenecaGlobalHerceptinMarkets & MarketingNovartisOncologyPharmaceuticalRochetamoxifen

Report: HER2-positive breast cancer market could treble in USA by 2023

Report: HER2-positive breast cancer market could treble in USA by 2023

02-10-2014

The US treatment market for human epidermal growth factor receptor type 2 (HER2)-positive breast cancer…

HerceptinMarkets & MarketingOncologyPharmaceuticalRocheUSA

Monoclonal antibodies set for a boom by 2019 due to favorable market conditions

Monoclonal antibodies set for a boom by 2019 due to favorable market conditions

15-09-2014

The monoclonal antibodies market for gastric and esophageal cancer is expected to double by 2019, according…

AntibodiesBiotechnologyEli LillyGlobalHerceptinnimotuzumabonartuzumabOncologypertuzumabramucirumabResearchRocheYM Biosciences

Compromised vials of Roche's MabThera found in Germany

Compromised vials of Roche's MabThera found in Germany

15-09-2014

Swiss drug major Roche has said that compromised vials of its arthritis and cancer drug MabThera had…

GermanyHerceptinLegalMabTheraOncologyPharmaceuticalProductionRegulationRoche

Benefits of Herceptin outweigh the risk of harm in advanced breast cancer

Benefits of Herceptin outweigh the risk of harm in advanced breast cancer

12-06-2014

In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug trastuzumab,…

HerceptinOncologyPharmaceuticalResearchRochetrastuzumab

EMA says that vials of falsified Herceptin have been identified

EMA says that vials of falsified Herceptin have been identified

16-04-2014

The European Medicines Agency says it has been informed that vials of Swiss drug major Roche’s blockbuster…

EuropeHealthcareHerceptinOncologyPharmaceuticalRegulationRoche

1 to 9 of 267 results

COMPANY SPOTLIGHT

Menarini

Back to top